Joseph H. Wender, Director at IONIS PHARMACEUTICALS INC (IONS), sold 56,000 shares at $80.67 ($4.5M) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($4.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.67 | 20,571 | $1.7M | 36.7% |
| 2 | $80.67 | 20,571 | $1.7M | 36.7% |
| 3 | $81.23 | 7,429 | $603K | 13.3% |
| 4 | $81.23 | 7,429 | $603K | 13.3% |
| Total | $80.82 avg | 56,000 | $4.5M | 100% |
| Filing → |
| IONS | SELL | 2025-09-04 | $1.6M | — | Filing → |
| IONS | SELL | 2019-03-20 | $796K | — | Filing → |
| IONS | SELL | 2018-05-11 | $1.3M | — | Filing → |